Last reviewed · How we verify
Autogenous Bone Graft
Autogenous Bone Graft is a Biologic drug developed by Cairo University. It is currently FDA-approved.
At a glance
| Generic name | Autogenous Bone Graft |
|---|---|
| Sponsor | Cairo University |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Using Different Biomaterials to Preserve Bone After Tooth Extraction (NA)
- Elamrousy Modified Approach for Socket Shield Technique (NA)
- Elamrousy Novel Approach of Socket Shield Technique (NA)
- A Prospective, Randomized, Single-blind, Controlled, Multi-center Study to Assess the Safety and Performance of MagnetOsTM Compared to Autogenous Bone Graft in Patients Undergoing Hindfoot or Ankle Fusions. (NA)
- Autogenous Periosteal Pedicle Graft Versus Pericardium Membrane in Management of Periodontal Intrabony Defects in Stage III Periodontitis (NA)
- Immediate Implant Placement With Autogenous Maxillary Tuberosity Graft in the Esthetic Zone (NA)
- Bilateral Alveolar Cleft Reconstruction Using Double Iliac Bone Blocks vs Particulate Grafting (NA)
- Bone Augmentation Techniques in the Mandible Posterior Region (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autogenous Bone Graft CI brief — competitive landscape report
- Autogenous Bone Graft updates RSS · CI watch RSS
- Cairo University portfolio CI
Frequently asked questions about Autogenous Bone Graft
What is Autogenous Bone Graft?
Autogenous Bone Graft is a Biologic drug developed by Cairo University.
Who makes Autogenous Bone Graft?
Autogenous Bone Graft is developed and marketed by Cairo University (see full Cairo University pipeline at /company/cairo-university).
What development phase is Autogenous Bone Graft in?
Autogenous Bone Graft is FDA-approved (marketed).
Related
- Manufacturer: Cairo University — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing